Workflow
Sono Group N.V. Reports Strong Commercial Momentum at Major European Trade Shows; Expands Market Reach with Dual November Exhibitions
Globenewswire· 2025-10-29 12:00
Sono Solar secures high-quality OEM and fleet leads at NUFAM and Busworld following partner integrations and live vehicle demonstrations; exploring marine applications at METSTRADE alongside continued road-transport focus at SOLUTRANSMunich, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Sono Group N.V. (Nasdaq: SSM) (hereafter referred to as “Sono” or the “Company”, parent company to Sono Motors GmbH, hereafter referred to as “Sono Solar” or “Subsidiary”), the solar technology company, today announced significant comme ...
EagleNXT Partners with Makville to Bring Cutting-Edge Drones to Egypt
Globenewswire· 2025-10-29 12:00
Cairo-Based Makville Business Consultation is newest authorized distributor in EagleNXT global network WICHITA, Kan., Oct. 29, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (dba, EagleNXT) (the “Company” or “EagleNXT”) (NYSE: UAVS), a leading provider of advanced drone and aerial imaging solutions, is pleased to announce the appointment of Makville Business Consultation, based in Cairo, Egypt, as an authorized distributor for EagleNXT senseFly drones. This strategic partnership expands EagleNXT’s gl ...
NanoXplore to Host a Webcast to Discuss First Quarter Results on November 13th, 2025
Globenewswire· 2025-10-29 12:00
MONTREAL, Oct. 29, 2025 (GLOBE NEWSWIRE) -- NanoXplore Inc. (“NanoXplore”) (TSX: GRA and OTCQX: NNXPF) is pleased to hold a webcast to discuss the results of its first quarter ended September 30th, 2025, on Thursday, November 13, 2025, at 10:00 a.m. Eastern Time. The financial results will be released on Wednesday, November 12, 2025, after the market close. Details of the Q1 Webcast When: November 13, 2025, at 10:00 a.m. Eastern Time Webcast: To listen to the live webcast, please join and register at: h ...
Sofwave to Participate in Upcoming November Investor Conferences
Globenewswire· 2025-10-29 12:00
SAN CLEMENTE, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that management will participate in the following investor conferences: Stifel 2025 Healthcare ConferencePresentation Format: Corporate overviewPresentation Date: Wednesday, November 12, 2025Presentation Time: 10:40 a.m. ETWebcast: Click Here Jefferies London Healthcare Conference Presentation Format: Corporate o ...
Vera Bradley Announces Appointment of Melinda Paraie as Chief Brand Officer
Globenewswire· 2025-10-29 12:00
Core Insights - Vera Bradley, Inc. has appointed Melinda Paraie as Chief Brand Officer effective November 1, 2025, to enhance its market position and consumer engagement [1][2][3] Company Overview - Vera Bradley is a leading designer of women's handbags, luggage, travel items, fashion and home accessories, and unique gifts, founded in 1982 [3] - The company operates through two reportable segments: Vera Bradley Direct (VB Direct) and Vera Bradley Indirect (VB Indirect) [4] Leadership and Strategy - Melinda Paraie brings extensive experience from brands like Coach and Cath Kidston, which will aid in product innovation and targeted marketing [2] - Paraie previously served as CEO of Cath Kidston and held significant roles at Tapestry, Inc., contributing to over $1 billion in sales growth outside North America during her tenure [2] Recent Contributions - Paraie has been working with Vera Bradley in a strategic consulting role for the past six months, making significant contributions to design and merchandising initiatives [3]
Rio2 Provides Fenix Gold Mine Q3 2025 Construction Update
Globenewswire· 2025-10-29 12:00
Core Points - Rio2 Limited provides an update on the Fenix Gold Project, which is 63% complete and on track for first gold production in January 2026 [1][3] Construction Progress - As of Q3 2025, a total of 1,865,791 person-hours have been worked with a Lost Time Incident Frequency Rate (LTIFR) of 1.61 and a Total Incident Frequency Rate (TIFR) of 8.58 [2] - Total expenditure since November 2024 is $86.7 million, slightly above the budget of $86.6 million [3] - 12.7 hectares of geosynthetics have been installed on the leach pad, ensuring six months of production capacity [4] - Mining of ore began in August, with 87,000 tonnes of ore placed on the leach pad at an average gold grade of 0.45 g/t, equating to 1,260 ounces [5] Infrastructure Development - The Pregnant Leach Solution (PLS) pond is complete and ready for hydrostatic testing, with water trucking initiated to fill the pond by mid-November [6] - Haul Road 1 is complete, and Haul Road 4 is largely finished [6] - Key components of the Adsorption, Desorption, Recovery (ADR) Plant have been installed, including diesel generators and reactors for chemical reactivation [7] Human Resources - The project currently employs 1,521 personnel, with 94% being Chileans, 44% from the Atacama Region, and 13% female [8] Exploration and Resource Management - Grade control drilling at Fenix South was completed in July, with preliminary analysis indicating close reconciliation of the grade control model to the reserve model [9] Future Milestones - Upcoming milestones include filling the PLS pond, leach process commissioning in November, plant commissioning in December/January, and the first gold pour in January 2026 [15]
IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site
Globenewswire· 2025-10-29 12:00
Core Insights - IN8bio, Inc. has announced the addition of The Ohio State University as a new clinical site for its ongoing Phase 1 trial of INB-100, a gamma-delta T cell therapy for leukemia patients undergoing haploidentical stem cell transplantation [1][2] Company Overview - IN8bio is a clinical-stage biopharmaceutical company focused on developing gamma-delta T cell-based immunotherapies for cancer and autoimmune diseases [4] - The lead program, INB-100, targets acute myeloid leukemia and evaluates haplo-matched allogeneic gamma-delta T cells administered post-hematopoietic stem cell transplant [4] Clinical Trial Details - The Phase 1 trial aims to assess the safety, durability, and anti-leukemic activity of INB-100 in the post-transplant setting [3] - Principal Investigator Dr. Joseph P. McGuirk leads the trial, which has shown encouraging long-term survival outcomes compared to historical data [3] - The trial has reported immune reconstitution, including the expansion and persistence of INB-100 gamma-delta T cells up to one year post-treatment, and an absence of severe graft-versus-host disease [3] Strategic Partnerships - The collaboration with The Ohio State University reflects strong interest in INB-100 and aims to accelerate enrollment in the Phase 1 trial [2] - The trial is expected to provide follow-up data next year, with multiple patients showing long-term leukemic remissions beyond four to five years [3]
FOREWARN to Provide Identity Verification Services to Salt Lake Board of REALTORS® to Promote Agent Safety
Globenewswire· 2025-10-29 12:00
The largest local REALTOR® Association in the state of Utah contracts to make FOREWARN services available for its 9,000+ real estate professional members to promote proactive agent safetyBOCA RATON, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that Salt Lake Board of REALTORS® will offer FOREWARN® services to its 9,000+ members it serves throughout Salt Lake City ...
Glucose Health, Inc. Appoints Strategic Investor Christopher J. Jemapete to Its Board of Directors
Globenewswire· 2025-10-29 12:00
BENTONVILLE, Ark., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) today announced a further strengthening of its Board of Directors with the appointment of Christopher J. Jemapete, effective today. Mr. Jemapete was an early strategic investor in Glucose Health, Inc. beginning in 2017 and continues to maintain a substantial equity position in the company. Mr. Jemapete brings three decades of experience in the financial services and securities industry to the Board of Directors of Glucose ...
Lead Real Estate Co., Ltd to Announce Fiscal Year 2025 Results and Host Conference Call on November 3, 2025, at 8:30 AM ET
Globenewswire· 2025-10-29 12:00
Core Viewpoint - Lead Real Estate Co., Ltd (LRE) is set to release its financial results for the fiscal year ended June 30, 2025, on November 3, 2025, before the U.S. market opens, followed by a conference call to discuss the results and outlook [1]. Company Overview - Lead Real Estate Co., Ltd is a Japanese developer specializing in luxury residential properties, including single-family homes and condominiums in Tokyo, Kanagawa Prefecture, and Sapporo [3]. - The company also operates the ENT TERRACE brand of extended-stay hotels and leases apartment units in Japan and Dallas, Texas [3]. Mission and Strategy - The company's mission is to provide stylish, safe, and luxurious living, guided by the philosophy of Kaizen (continuous improvement) to enhance operational efficiency [4]. - LRE aims to expand its award-winning luxury housing and hotel portfolio while building a global real-estate transaction platform that offers access to prime properties in Japan and internationally, including the U.S. and Hong Kong [4]. Conference Call Details - The conference call to discuss the fiscal year 2025 earnings will take place on November 3, 2025, at 8:30 AM Eastern Time (10:30 PM Japan Standard Time) [2]. - Participants can join the call via a toll-free number in the U.S. or an international dial-in number, with a conference ID provided for access [2].